Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

QGEN

QIAGEN N.V.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1015820Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.09B
Net Income FY2025
$0.43B
EPS (Basic, as reported)
$1.96
Net Margin FY2025
20.3%
ROE FY2025
11.2%
Total Equity
$3.78B
Shares Out
217M
Business description

QIAGEN N.V. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 20-F (foreign private issuer annual report) via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 1,338 → 2,090 +5.1% CAGR
Revenue1,3381,4181,5021,5261,8702,2522,1421,9651,9782,090
Cost of revenue(493)(495)(501)(521)(638)(801)(757)(732)(1,011)(791)
Gross profit8459231,0011,0051,2331,4511,3851,2349671,299
Selling & marketing(401)(376)(392)(392)(414)(456)(474)(460)(451)(458)
General & administrative—(102)(105)(112)(112)(128)(130)(119)(113)(126)
Total operating expenses(746)(769)(734)(1,031)(846)(821)(853)(824)(870)(834)
Operating income99153267(26)38663053141098466
Interest expense(39)(50)(67)(74)(71)(54)(58)(53)(44)(33)
Interest & investment income7112122101033796864
Other income (expense), net(42)(39)(41)(52)53(4)(19)202324
Pre-tax income57114226(78)439626513430121490
Income tax expense(23)(74)(35)(36)(80)(113)(89)(89)(38)(65)
Net income8040190(41)35951342334184425
EPS — basic$0.34$0.18$0.84($0.18)$1.57$2.25$1.86$1.50$0.38$1.96
EPS — diluted$0.34$0.17$0.82($0.18)$1.53$2.21$1.84$1.48$0.37$1.94
Shares outstanding — basic (M)235228227227228228228228223217
Shares outstanding — diluted (M)239233233227234232230231225219

Showing the latest 10 of 18 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.